Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg “All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)”
study id #: NCT03555578
condition: Spinal and Bulbar Muscular Atrophy
status: Recruiting
purpose:The purpose of this survey is to evaluate the long-term safety and efficacy of leuprorelin acetate injection kit 11.25 mg in patients with spinal and bulbar muscular atrophy (SBMA) in the routine clinical setting.
intervention: Leuprorelin Acetate
results: https://clinicaltrials.gov/ct2/show/results/NCT03555578
last updated: February 04, 2022
-
Learning Center Progress in Spinal Muscular Atrophy Managementhttps://sma.elsevierresource.com/sites/s...
-
Sofia’s Story – Johns Hopkin’sOn the morning of Friday, Aug. 23, 2019,...
-
Spinal Muscular Atrophy (SMA)Spinal muscular atrophy (SMA) is a genet...
-
A Novel CARM1-HuR Axis Involved in Muscle Differentiation and Plasticity Misregulated in Spinal Muscular AtrophySpinal muscular atrophy (SMA) is charact...
-
SMA Angels Charity – Facebook100% Volunteer, 501 (c)(3) non-profit de...
-
George Z. Mentis, PhDGeorge Mentis received pursued B.Sc in P...
-
Looking After Yourself if you’re an Adult Who Has Had a Recent Diagnosis of SMASMA Type 4, the more common form of adul...